John Brendan Doyle Insider Profile
11 Followers
John Brendan Doyle, CFO at Cognition Therapeutics, holds 618.94K shares in Cognition Therapeutics (Ticker: CGTX), holds ― shares in Chiasma (Ticker: CHMA).
John Brendan Doyle has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Brendan Doyle's holdings
Insider Roles
CFO
Roles that John Brendan Doyle holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Brendan Doyle
John Brendan Doyle's Trading History
Cognition Therapeutics
May 04, 2026
CFO
Uninformative Sell
10.97K
$637.51K
Chiasma
―
―
―
―
List of latest transactions for each holding click on a transaction to see John Brendan Doyle's performance on stock
You May Also Like
John Brendan Doyle insider profile FAQ
What is the percentage of profitable transactions made by John Brendan Doyle?
The percentage of profitable transactions made by John Brendan Doyle is ―.
What is the average return per transaction made by John Brendan Doyle?
The average return per transaction made by John Brendan Doyle is ―.
What stocks does John Brendan Doyle hold?
John Brendan Doyle holds: CGTX, CHMA stocks.
What was John Brendan Doyle’s latest transaction?
John Brendan Doyle latest transaction was an Uninformative Sell of $10.97K.
What was John Brendan Doyle's most profitable transaction?
John Brendan Doyle’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Brendan Doyle's role in Cognition Therapeutics?
John Brendan Doyle's role in Cognition Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.